Dermatology8 min read2 October 2026Dewansh Choudhary

Quantitative Hemoglobin & Water Biomarker Mapping: Multispectral Diagnostics for Inflammatory Skin Diseases

The integration of subsurface chromophore unmixing via handheld multispectral imaging provides a transformative solution. By isolating specific absorption and scattering bands across the visible and near-infrared (VIS-NIR) spectra, advanced optical devices generate quantitative, spatially resolved heatmaps of oxygenated hemoglobin ($\text{HbO}_2$), deoxygenated hemoglobin ($\text{HHb}$), and tissue water content ($H_2O$). This non-contact approach bridges the gap between clinical observation and objective molecular pathology—delivering a robust non-contact skin barrier diagnostic for clinical dermatology and pharmaceutical drug trials.

Evaluating inflammatory dermatoses such as psoriasis, atopic dermatitis (eczema), rosacea, and contact dermatitis remains heavily dependent on qualitative visual scoring tools. Standard clinical indices like the Psoriasis Area and Severity Index (PASI), Eczema Area and Severity Index (EASI), and Scoring Atopic Dermatitis (SCORAD) suffer from significant intra- and inter-observer variability. Furthermore, visual inspection under broad white light ( $400\text{ nm} - 700\text{ nm}$ ) evaluates only surface-level erythema and scaling, failing to capture underlying microvascular dilation, tissue hypoxia, or stratum corneum barrier disruption.

The integration of subsurface chromophore unmixing via handheld multispectral imaging provides a transformative solution. By isolating specific absorption and scattering bands across the visible and near-infrared (VIS-NIR) spectra, advanced optical devices generate quantitative, spatially resolved heatmaps of oxygenated hemoglobin ( $\text{HbO}_2$ ), deoxygenated hemoglobin ( $\text{HHb}$ ), and tissue water content ( $H_2O$ ). This non-contact approach bridges the gap between clinical observation and objective molecular pathology delivering a robust non-contact skin barrier diagnostic for clinical dermatology and pharmaceutical drug trials.

The Biophysical Mechanics of Multispectral Chromophore Unmixing

Human skin tissue behaves as a complex turbid medium where optical attenuation is governed by light absorption from specific biological chromophores and light scattering from structural dermal collagen.

   SPECTRAL CHROMOPHORE ABSORPTION BANDS
                      
  [ 405nm - 435nm ] ──> Soret Peak: High Oxy & Deoxyhemoglobin Absorption
  [ 542nm & 577nm ] ──> Dual Oxyhemoglobin (HbO2) Isobestic Q-Bands
  [ 660nm - 750nm ] ──> Deoxyhemoglobin (HHb) Relative Dominance Region
  [ 945nm & 1450nm] ──> NIR Hydroxyl (O-H) Water Band (Hydration & Edema)

To perform oxyhemoglobin deoxyhemoglobin spectral mapping, multispectral systems model attenuation using a modified Beer-Lambert formulation adapted for diffuse reflectance in scattering tissue:

A(\lambda) = \ln\left(\frac{I_0(\lambda)}{I(\lambda)}\right) = \left[ \varepsilon_{\text{HbO}_2}(\lambda) C_{\text{HbO}_2} + \varepsilon_{\text{HHb}}(\lambda) C_{\text{HHb}} + \varepsilon_{\text{water}}(\lambda) C_{\text{water}} + \varepsilon_{\text{mel}}(\lambda) C_{\text{mel}} \right] L(\lambda) + S(\lambda)

Where:

$I_0(\lambda)$ and $I(\lambda)$ represent incident and diffusely reflected light intensities at wavelength $\lambda$ .
$\varepsilon_x(\lambda)$ is the molar extinction coefficient of chromophore $x$ .
$C_x$ represents the volumetric concentration of each target biomarker.
$L(\lambda)$ is the mean differential optical path length through the dermal layers.
$S(\lambda)$ represents wavelength-dependent tissue scattering losses.

By capturing millisecond exposures across targeted discrete spectral channels, high-speed matrix inversion algorithms unmix overlapping absorption signatures, isolating individual biomarker maps with pixel-level spatial accuracy.

Technical Comparison: Standard Visual Scoring vs. Multispectral Biomarker Profiling

Performance Parameter	Clinical Visual Scoring (PASI / EASI)	Contact Biophysical Probes (TEWL / Corneometer)	Multispectral Biomarker Mapping
Objectivity	Qualitative (High observer variance)	Quantitative (Subject to probe contact pressure)	Fully Quantitative & Spatially Resolved
Erythema Discrimination	Confounded by skin phototype (Fitzpatrick I-VI)	N/A (Measures electrical/capacitive properties)	Isolates true $\text{HbO}_2$ absorption from epidermal melanin
Vascular Dynamics	Cannot differentiate active vs passive hyperemia	None	Computes relative tissue oxygen saturation ( $\text{StO}_2$ )
Skin Barrier Evaluation	Evaluates secondary visual scaling/flaking	Measures localized water evaporation at single point	Non-contact optical water absorption mapping across wide FOV
Clinical Trial Utility	Delayed response tracking (weeks)	High variance across test sites	Captures sub-clinical anti-inflammatory response in days

Advanced Applications in Clinical & Experimental Dermatology

 MULTISPECTRAL DIAGNOSTIC PIPELINE
                                          │
    ┌─────────────────────────────────────┼─────────────────────────────────────┐
    ▼                                     ▼                                     ▼
[Erythema Quantification]      [Skin Barrier Diagnostic]             [Spectral Classifier AI]
- Oxy vs Deoxy Hemoglobin      - Stratum Corneum Hydration           - Psoriasis vs Eczema
- StO2 Saturation Maps         - Dermal Edema Localization           - Sub-Clinical Flare Detection
- Active vs Inactive Lesions   - Non-Contact TEWL Estimation         - Drug Efficacy Monitoring

1. Multispectral Skin Erythema Quantification & Cutaneous Microvascular Imaging

Visual assessment of erythema frequently fails in darker skin tones (Fitzpatrick phototypes IV–VI), where high epidermal melanin concentration masks underlying vascular dilation. Multispectral skin erythema quantification eliminates melanin interference by evaluating the differential absorption slopes across $542\text{ nm}$ and $577\text{ nm}$ .

Simultaneously, evaluating the ratio between oxygenated and deoxygenated hemoglobin yields tissue oxygen saturation maps:

\text{StO}_2 = \frac{C_{\text{HbO}_2}}{C_{\text{HbO}_2} + C_{\text{HHb}}} \times 100\%

Active Inflammatory Flares: Characterized by hyper-perfusion, rapid arterial flow, and elevated $\text{StO}_2$ ( $>85\%$ ) due to local cytokine-mediated vasodilation.
Chronic / Stagnant Lesions: Display venous stasis with elevated total hemoglobin ( $C_{\text{HbO}_2} + C_{\text{HHb}}$ ) but depressed $\text{StO}_2$ ( $<60\%$ ), allowing clinicians to distinguish active disease activity from post-inflammatory hyperpigmentation (PIH).

2. Non-Contact Skin Barrier Assessment & Optical TEWL Evaluation

Traditional assessment of epidermal barrier dysfunction relies on mechanical evaporimeters to measure Transepidermal Water Loss (TEWL). However, physical contact probes alter local skin microclimates, introduce contact pressure artifacts, and cannot be used on delicate or open lesions.

Optical non-contact skin barrier assessment evaluates light absorption at $945\text{ nm}$ and $1450\text{ nm}$ wavelengths corresponding to the vibrational overtone bands of hydroxyl ( $\text{O-H}$ ) chemical bonds in water molecules:

Stratum Corneum Dehydration: Reduced $945\text{ nm}$ absorption in the superficial epidermal layers signals barrier breakdown and reduced Natural Moisturizing Factor (NMF) content.
Dermal Edema Detection: Increased NIR water band absorption in the deeper dermis identifies intracellular fluid accumulation and inflammatory swelling before macroscopic papules or wheals become visible.

3. AI-Driven Psoriasis & Eczema Spectral Classifiers

While plaque psoriasis and atopic dermatitis may exhibit similar visual redness and flaking during acute exacerbations, their underlying histopathology and vascular architecture differ fundamentally. Psoriasis features elongated, tortuous papillary capillaries, whereas eczema involves diffuse dermal edema and patchy microvascular ectasia.

By training deep convolutional neural networks on multi-band spectral hypercubes, a psoriasis eczema spectral classifier analyzes both spatial vascular geometry and spectral absorption ratios simultaneously. These models achieve high diagnostic accuracy in differentiating ambiguous inflammatory presentations without invasive punch biopsies.

Hardware Architecture: Engineering High-Fidelity Multispectral Systems

To transition quantitative optical spectroscopy into routine clinical practice and decentralized trial sites, hardware designs must overcome ambient light interference, surface glare, and motion artifacts.

┌─────────────────────────────────────────────────────────────────────────────┐
│                 MULTISPECTRAL DERMATOLOGY HARDWARE ENGINE                   │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Synchronized LED Array   │ Pulsed narrow-band LEDs ($405\text{ nm} -        │
│                          │  $945\text{ nm}$ ) with  $&lt;10\text{ nm}$  FWHM.      │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Cross-Polarization Optics│ Motorized linear polarizers eliminating          │
│                          │ stratum corneum specular reflections.            │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ High Quantum Efficiency  │ Low-noise global shutter sensor capturing        │
│ Sensing Matrix           │ synchronous multi-band frames in  $&lt;50\text{ ms}$ .│
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Onboard Edge Computing   │ Real-time matrix inversion and chromophore       │
│                          │ unmixing rendering instant UI heatmaps.          │
└──────────────────────────┴──────────────────────────────────────────────────┘

Narrowband Pulsed Illumination: High-power LED rings sequentially pulse discrete wavelengths ( $405\text{ nm}$ , $435\text{ nm}$ , $542\text{ nm}$ , $577\text{ nm}$ , $660\text{ nm}$ , $945\text{ nm}$ ) within milliseconds, eliminating thermal load while maintaining high signal-to-noise ratios (SNR).
Synchronized Cross-Polarization: Interlocking linear polarizers positioned over the light sources and camera lens block specular reflections from the skin surface, ensuring captured light consists purely of deep backscattered photons from the dermal matrix.
Real-Time Edge Unmixing: Integrated GPU microprocessors compute matrix inversions on-device, generating calibrated $\text{HbO}_2$ , $\text{HHb}$ , and $H_2O$ concentration overlays directly on an interactive touchscreen within seconds of exposure.

Accelerating Pharmaceutical R&D and Dermatology Clinical Trials

For contract research organizations (CROs) and pharmaceutical sponsors developing topical anti-inflammatory agents, biologics, or barrier-repair formulations, multispectral biomarker mapping offers distinct trial advantages:

Objective Endpoints: Replaces subjective visual scoring with continuous, quantifiable metrics ( $\text{mg/dL}$ tissue hemoglobin equivalents, relative $\text{StO}_2\%$ , and hydration indices).
Early Efficacy Detection: Detects sub-clinical vascular shut-down and re-hydration within $24-48\text{ hours}$ of drug application, weeks before visual lesions clear.
Standardized Multi-Site Data: Calibrated optical targets ensure data uniformity across international trial centers, reducing required patient cohort sizes.

Transform Your Clinical Research with Quantitative Multispectral Optics

Moving beyond qualitative visual scoring is no longer a future concept it is an operational necessity for modern clinical dermatology and pharmaceutical development. Incorporating high-speed oxyhemoglobin deoxyhemoglobin mapping and optical water profiling empowers clinical teams to quantify disease severity with unparalleled precision.

Ready to integrate quantitative multispectral diagnostics into your clinical workflow or upcoming pharmaceutical trial?

[Speak with Our Optical Applications Team] to review hardware integration options, request benchmark validation data, or schedule an interactive clinical demonstration.

Explore Phosic's Technology

See how hyperspectral intelligence is deployed across critical domains in the field, in real time.

Our Technology